Lyons, Alexis B.
Kohli, Indermeet
Nahhas, Amanda F.
Braunberger, Taylor L.
Mohammad, Tasneem F.
Nicholson, Cynthia L.
Nartker, Nathan T.
Modi, Krishna
Matsui, Mary S.
Lim, Henry W.
Hamzavi, Iltefat H.
Funding for this research was provided by:
Unigen Inc
Article History
Received: 15 January 2020
Revised: 27 February 2020
Accepted: 30 March 2020
First Online: 6 April 2020
Compliance with ethical standards
:
: Dr. Lyons is a sub-investigator for Incyte, Bayer, Unigen Inc., Lenicura, Estee Lauder, Miragen, Biofrontera. Dr. Kohli is a sub-investigator for Bayer, Estee Lauder, Unigen Inc., Ferndale laboratories, Allergan, Johnson & Johnson, Chromaderm, and Pfizer. Dr. Nahhas and Dr. Braunberger are sub-investigators for Bayer, Estee Lauder, Unigen Inc., and Ferndale laboratories. Dr. Mohammad, Dr. Nicholson, Nathan Narkter, and Krishna Modi have no relevant conflicts of interest to declare. Dr. Matsui was an employee of Estee Lauder. Dr. Lim is an investigator for Estee Lauder, Allergan, Ferndale laboratories, and Unigen Inc., and has served as a consultant to Pierre Fabre and ISDIN. Dr. Hamzavi is an investigator for Unigen Inc., Allergan, Clinuvel, Galderma, L’Oreal, PCORI, Pfizer, Incyte Corporation, Bayer, Estee Lauder, Ferndale Healthcare Inc., Lenicura, General Electric, Janssen Biotech, and Johnson & Johnson and is the co-chair of the Global Vitiligo Foundation (unpaid), is on AbbVie advisory board (unpaid), and is a consultant for Incyte.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Henry Ford Hospital (IRB 9920).
: Portions of this manuscript have been presented orally at the Society of Investigative Dermatology: Research in cutaneous surgery minisymposium on May 16, 2018 in Orlando, FL, at the Henry Ford Hospital Medical Education Research Forum on May 11, 2018 in Detroit, MI, at the American Academy of Dermatology Annual Meeting on March 3, 2019 in Washington, DC. Portions of this manuscript have been presented as a poster at the International Investigative Dermatology annual meeting on May 16–19, 2018 in Orlando, FL, the Annual Skin of Color Symposium on February 15, 2018 in San Diego, CA, and the World Congress of Dermatology on June 11–15 in Milan, Italy.